The Changing Face of Beauty: What the UK Evidence Really Says About Dermal Fillers

By Dr Prerna Mittal, GMC- 6043764

When a side-by-side of a famous celebrity goes viral “before and after, “on Tik Tok, “Bradley Cooper no more,” “RIP the old jawline” the comments tell you everything about how far the conversation has gone. Some people mourn the old look, some defend the new one, and almost everyone has an opinion on fillers. At Hunar Clinic, we think those opinions deserve better than speculation. So here is what the UK evidence says, the British College of Aesthetic Medicine (BCAM), recent clinical reviews, the aesthetics journals, and the 2026 Women and Equalities Committee parliamentary inquiry, tells us about the gaps in the regulation of non-surgical treatments like fillers in 2026.

A treatment that quietly became mainstream

We use dermal fillers are injectable gels to restore lost volume, refine contours and improve skin quality. The most commonly used are hyaluronic acid (HA) fillers, a synthetic form of a sugar molecule the body already produces, which attracts and holds water, adding volume while hydrating the tissue around it. My favourite categories include Polycaprolactone (PCL), calcium hydroxyl apatite and collagen-stimulating fillers, which work less by filling and more by prompting your own collagen to rebuild over time. The scale of this has become genuinely significant.

Injectable such as Botox and fillers together, now make up roughly 65% of the UK aesthetics market’s revenue, and account for around 9 in 10 cosmetic procedures performed in the country. The UK aesthetics sector is now thought to span around 16,000 businesses, and the broader cosmetic and personal-care sector contributed an estimated £24.5bn to UK GDP in 2022. The UK dermal filler market alone was valued in the region of £280m–£440m in recent estimates and is forecast to keep growing through the early 2030s. Demand skews younger than many assume: over half of UK filler patients are now under 35, driven by a shift toward ‘prejuvenation’ preventative, light-touch treatment rather than late correction.

Why celebrities changed the conversation – twice

I believe, one cannot tell the story of fillers without celebrity culture, because public figures have shaped the demand twice, first by popularising fillers, and then by popularising their reversal. The first wave is well documented, when Kylie Jenner admitted to lip injections in 2015, lip, cheek, and chin and jaw filler boomed through the 2010s. Social media, Instagram and later TikTok turned a private clinical procedure into an aspirational, shareable look which when I decided to educate my clients about balanced way of doing aesthetical procedures. For roughly a decade, “more” was the aesthetic, but, I believed it was important for the clients to know that ‘Less is more’.

Then the pendulum swung, and the same culture that sold volume began selling restraint. When former Love Island star Molly-Mae Hague had her filler dissolved in October 2020, it became a cultural moment in the UK. Kylie Jenner stepped out with a notably softer, deflated look in 2021 and by 2024–2025, commentators were describing a “de-Kardashianification”, a move away from exaggerated, curvy, conspicuously-enhanced features toward something subtler. As at the Hunar Clinic, I, Dr. Prerna Mittal always preach, good cosmetic work is “meant to look naturally enhanced and not meant to look exaggerated.” The UK data echoes the cultural shift: according to the British Association of Aesthetic Plastic Surgeons, the number of filler procedures fell by around 26% in 2023 compared with the previous year, as the “less is more” approach took hold. The clearest example of the reset is Lindsay Lohan. Her 2024–2025 transformation, widely attributed by practitioners to dissolved old filler combined with skin-quality work and a holistic approach, something that sparked enormous discussion precisely because it looked refreshed rather than “done.” Lohan herself has denied a facelift, crediting skincare, Botox and lifestyle; her father has acknowledged she has previously had “peels, fillers and Botox.” The point that always fascinates me is that this “undetectable” look represents something bigger than a passing trend which makes me look a bit conservative in my way approach.

Male faces are now part of this conversation too. The viral “changing face of Bradley Cooper” debate is a good example: side-by-side images of the actor over the years have prompted widespread online speculation about whether subtle differences, apparently wider-looking eyes, fuller cheeks, a more defined jawline, reflect cosmetic tweaks, or simply natural ageing, weight changes, styling and lighting. To be clear, Cooper has not publicly confirmed any treatment, and I am not suggesting he has; the interest here is in the discussion itself. It shows how closely public figures are now scrutinised, how readily the internet reaches for “filler” as an explanation, and how the same features people once celebrated can become a talking point overnight. This is the crucial nuance the viral “celebrity ruined their face” posts miss. The lesson from the last five years is not that fillers don’t work; it’s that visible fillers were never the goal. The faces people admire most are usually the ones where the work was conservative, well-planned and barely detectable.

The honest part: what has gone wrong

A balanced report has to address the harm, because there has been real harm, and in the UK it has become a matter of national policy. The structural problem is that, historically, there have been no legal standards for who can inject fillers. MPs have repeatedly described the sector as a “Wild West.” The consequences show up in the complaint data: the government-approved register Save Face received nearly 3,000 complaints in 2022, and somewhere between 65% and 67% of those related to dermal fillers. According to the data and BCAM Clinical reviews most poor outcomes trace back to the same root causes; inadequate practitioner training, the wrong product in the wrong anatomical plane, and social-media trends that encouraged excessive treatment. The “pillow face” and “filler fatigue” that drove the celebrity reset are, in large part, the visible residue of overtreatment.

The UK is now acting on this. In February 2026, Parliament’s Women and Equalities Committee published a major report concluding that demand for cosmetic procedures has grown significantly while regulation has failed to keep pace, allowing inadequately trained individuals to carry out high-risk procedures that I often phrase as, “too often and with devastating consequences.”

Building on powers in the Health and Care Act 2022, the government has set out a risk-based licensing scheme: the highest-risk (“red”) procedures, including dermal filler used to augment areas such as the breasts, buttocks and genitals, would be restricted to qualified, regulated healthcare professionals and brought under Care Quality Commission oversight. As at Hunar Clinic, we are CQC registered, treating under-18s for cosmetic reasons has already been illegal and not entertained. The MHRA also intends to regulate fillers more like medical devices.

None of this is anti-filler. It is anti-bad-practice, and that distinction matters enormously for me.

What the safety evidence actually shows

So are fillers dangerous?
The honest, evidence-based answer is that risk depends overwhelmingly on the injector, not the injectable. I always suggest doing your own research and checking the experience and training of the injector.

The genuinely serious complication is vascular occlusion, filler inadvertently entering or compressing a blood vessel, which in rare cases can threaten the skin or, very rarely, vision. This is exactly why anatomical knowledge and technique are non-negotiable, and why a 2025 systematic review and meta-analysis set out to quantify the risk factors involved. Most other adverse effects are far less severe: redness, swelling and bruising that settle within days, and less commonly lumps, nodules or infection.

International expert-consensus guidance now exists for recognising and managing each of these, and HA fillers carry an additional safety advantage, they can be dissolved with the enzyme hyaluronidase if something isn’t right or the patient simply changes their mind. The clinical consensus for 2026 is consistent: fillers are generally safe when the right product is placed in the right anatomy, with the right technique, by a properly trained medical injector working in a clinic prepared to manage complications. As a member of BCAM, I, Dr Mittal always stresses, an appropriately trained practitioner should explain the warning signs to watch for and provide emergency contact details. Fillers are also not for everyone, BCAM advises against treatment during active skin infections, pregnancy and breastfeeding, or with certain medical conditions and allergies. Why well-done fillers genuinely help with the caveats stated honestly, it is worth being equally honest about the upside, because for the right patient, in the right hands, fillers do real good.

I always stress on the fact that Age with Grace as, Faces lose volume with age. Fat pads descend, bone remodels, and the scaffolding that gives a youthful face its structure quietly recedes. Skilfully placed filler or collagen stimulator like Ellanse’, restores that lost support, lifting a flattened cheek, softening a deepened fold, refining a jawline, and the best results don’t read as “filler” at all. They read as rested. This is the concept of undetectable aesthetics: not changing someone into a different person, but returning them to a fresher version of themselves.

The benefits are not only physical. Used judiciously, these treatments can meaningfully improve confidence and self-image, which is a large part of why demand has held up despite all the scrutiny. HA fillers are also temporary and reversible, which makes them a comparatively low-commitment, non-surgical route to rejuvenation, one reason I believe, is “prejuvenation” with small, conservative doses has become the defining trend rather than dramatic overhaul.

The wider 2025–2026 shift toward regenerative and collagen-supporting approaches reflects the same philosophy: support the face’s natural structure over time rather than chase individual lines.

Good work versus bad work;
If there is a single takeaway, it is that the difference between a result people admire and one they mock is almost entirely about how the treatment was done. Excellent filler work starts with a proper facial assessment and an individualised plan. It is conservative rather than aggressive, building gradually, respecting natural proportions, and aiming for balance and harmony rather than maximum volume. It treats the face as a whole, not a checklist of areas to inflate. Poor work does the opposite: it over-fills, ignores anatomy, distorts proportions, and chases a trend instead of suiting the individual.

Remember, the “changing face” debates that go viral are usually arguments about this, not about whether fillers can look good, but about whether a particular result was tasteful and well-judged. This is why the leading voices in UK aesthetic medicine increasingly emphasise the same things: natural-looking outcomes, careful patient selection, ethical practice, and the discipline to say no to a patient asking for too much, which I respectfully follow in my practice.

The bottom line, dermal fillers are neither the villain nor the miracle the internet makes them out to be. The strongest evidence says this: in trained, medically-qualified hands, with conservative dosing and a naturally enhanced results philosophy, fillers are a safe, reversible and genuinely effective way to restore volume and confidence. In the wrong hands, they are the single biggest source of complaints in UK aesthetics, which is exactly why Parliament is moving to regulate the field.

The celebrity reset of the last five years didn’t kill fillers. It refined the goal. The faces we now admire most are the ones where you can’t quite tell anything was done at all. That is the standard worth holding any clinic, including ours too.

Key Takeaways: 20 Evidence-Based Insights

1. “Dermal fillers, when correctly selected and placed, restore lost volume, refine facial contours and improve skin quality. At Hunar Clinic, Dr Mittal works exclusively with hyaluronic acid fillers: the most evidence-backed and widely recommended option in modern aesthetic medicine.”
2. “Hyaluronic acid is not a foreign substance, it is one your body produces naturally. HA fillers leverage this biology, attracting and retaining water to add volume while actively hydrating surrounding tissue. The result is enhancement that integrates, rather than sits on top.”
3. “Injectables now account for roughly 65% of UK aesthetics market revenue and approximately nine in ten cosmetic procedures. The scale of demand makes practitioner selection, not treatment availability, the defining variable in patient outcomes.”
4. “More than half of UK filler patients are now under 35, reflecting a fundamental shift in how younger generations approach skincare. Prejuvenation, subtle preventative treatment to maintain rather than reverse, is the philosophy at the core of Dr Mittal’s practice.”
5.  “The 2010s filler boom, catalysed by celebrity admissions and amplified by social media, brought aesthetic treatment into the mainstream. It also, in time, produced the visual excesses that would come to define what patients no longer want.”
6. “The cultural pivot toward filler reversal, most notably from 2020 onward, was not a rejection of aesthetics. It was a correction toward authenticity. Dr Mittal has always offered dissolution consultations, and treats the desire to reverse as equal to the desire to treat.”
7. “The defining aesthetic of 2024 and 2025 is transformation that leaves no trace. The most admired results, among patients and clinicians alike, are those where enhancement is present but attribution is impossible.”
8. “Public scrutiny of celebrity faces reflects a wider cultural intelligence around aesthetic work. The patient of 2026 knows what over-treated looks like, and comes to Dr Prerna Mittal precisely because they want the opposite.”
9. “A reported 26% decline in UK filler procedures in 2023 (BAAPS) tells a clear story: the market is self-correcting toward quality. Practitioners who built their reputations on natural, conservative results are those best positioned for what comes next.”
10. “The clearest lesson of the last decade in aesthetics is also the simplest: the goal was never visible fillers. It was always undetectable, balanced work that improves without announcing itself. That has been Dr Prerna Mittal’s clinical standard from the outset.”
11. “Pillow face and filler fatigue are not arguments against dermal fillers, they are arguments against overtreatment. Used correctly, with appropriate volumes and precise anatomical placement, HA filler produces outcomes that are both seamless and long-lasting.”
12. “Save Face’s recording of nearly 3,000 complaints in 2022, the majority filler-related, underscores a single truth: the risk in aesthetic medicine is not the treatment, it is the practitioner. At CQC registered Hunar Clinic, every injection is performed by Dr Mittal personally.”
13. “The description of UK aesthetics as a ‘Wild West’ by members of parliament is not an exaggeration, it is a clinical reality. Dr Prerna Mittal, member of BCAM supports statutory regulation and has long operated to a standard that forthcoming legislation will formally require of all practitioners.”
14. “Analysis of poor aesthetic outcomes consistently identifies three root causes: inadequate training, incorrect product and placement decisions, and treatment driven by trend rather than clinical need. Dr Mittal’s protocol is specifically designed to eliminate all three.”
15. “The February 2026 Women and Equalities Committee report confirmed what clinicians already knew: UK aesthetics regulation has not kept pace with public demand. The incoming licensing framework represents an overdue and welcome correction.”
16.  “Under the UK’s planned licensing scheme, the highest-risk filler procedures will be classified as ‘red’ and restricted to regulated healthcare professionals under CQC oversight. Dr Prerna Mittal, GMC registration – 6043764 already operates within and beyond these standards.”
17. “The 2021 Botulinum Toxin and Cosmetic Fillers (Children) Act made it illegal to treat under-18s with cosmetic injectables. Hunar Clinic enforces this without exception, and Dr Mittal will not provide treatment to anyone under the age of 18 under any circumstances.”
18.  “Vascular occlusion, the obstruction of a blood vessel by displaced filler is rare, but it is the most serious potential complication in aesthetic injectable treatment. It is the primary reason that anatomical knowledge is not optional; it is the foundation of safe practice.”
19.  “The most common side effects of dermal filler, temporary redness, swelling and bruising at the injection site, are mild and typically resolve within days. Dr Prerna Mittal provides comprehensive aftercare guidance and follows expert consensus protocols for all complication management.”
20. “One of the most significant clinical advantages of hyaluronic acid filler is reversibility. HA can be fully dissolved using hyaluronidase, giving patients both a safety net and the freedom to adjust their results over time. This is a primary reason Dr Mittal works exclusively with HA products.”
21. “The clinical consensus entering 2026 is unambiguous: dermal fillers are safe provided the correct product is selected, anatomical knowledge is applied, technique is sound, and the injector is properly trained and medically qualified. Hunar Clinic meets every criterion.”